English
Mocetinostat (MGCD0103) , CAS 726169-73-9
Mocetinostat (MGCD0103) , CAS 726169-73-9
Artikelnummer
BPS27109
Verpackungseinheit
5 mg
Hersteller
BPS Bioscience
Verfügbarkeit:
wird geladen...
Preis wird geladen...
Products from BPS Bioscience require a minimum order value above 400€
Biological Activity: Mocetinostat (MGCD0103) inhibits HDAC1, HDAC2 and HDAC3 with IC50 values of 0.15 µM, 0.29 µM and 1.66 µM, respectively.
CAS Number: 726169-73-9
Description: Mocetinostat (MGCD0103) is an HDAC inhibitor. It was shown to induce hyperacetylation of histones resulting in cancer cell selective apoptosis, and cause cell cycle blockade in various human cancer cell lines in a dose-dependent manner. Mocetinostat inhibites growth of human tumor xenografts in nude mice in a dose-dependent manner and its antitumor activity correlates with induction of histone acetylation in tumors.
Format: A crystalline solid
Purity: ≥99% by HPLC
Solubility: Solubility in DMSO is 13 mg/ml, and in water and ethanol is < 1 mg/ml. DMSO stock solutions are stable up to one week at 4°C or up to a month at -70°C. Do not store aqueous solutions for more than one day.
Storage Stability: Store at or below -20°C. Solid form is stable at least 2 years from date of receipt, when stored as directed. Do not store aqueous solutions for more than one day.
Biosafety Level: Not applicable (BSL-1)
References: 1. Foumel, M., et al., Mol Cancer Ther. 2008;7:759-768.
2. Duque-Afonso, J., et al. Oncogene 2011. July;30:3062-72.
3. Munkacsi, A.B., et al. J. Biol. Chem. 2011. July;286:23842-51.
4. Xu, X., et al. PLoS ONE. February 2011. 6:e17138.
Biological Activity: Mocetinostat (MGCD0103) inhibits HDAC1, HDAC2 and HDAC3 with IC50 values of 0.15 µM, 0.29 µM and 1.66 µM, respectively.
CAS Number: 726169-73-9
Description: Mocetinostat (MGCD0103) is an HDAC inhibitor. It was shown to induce hyperacetylation of histones resulting in cancer cell selective apoptosis, and cause cell cycle blockade in various human cancer cell lines in a dose-dependent manner. Mocetinostat inhibites growth of human tumor xenografts in nude mice in a dose-dependent manner and its antitumor activity correlates with induction of histone acetylation in tumors.
Format: A crystalline solid
Purity: ≥99% by HPLC
Solubility: Solubility in DMSO is 13 mg/ml, and in water and ethanol is < 1 mg/ml. DMSO stock solutions are stable up to one week at 4°C or up to a month at -70°C. Do not store aqueous solutions for more than one day.
Storage Stability: Store at or below -20°C. Solid form is stable at least 2 years from date of receipt, when stored as directed. Do not store aqueous solutions for more than one day.
Biosafety Level: Not applicable (BSL-1)
References: 1. Foumel, M., et al., Mol Cancer Ther. 2008;7:759-768.
2. Duque-Afonso, J., et al. Oncogene 2011. July;30:3062-72.
3. Munkacsi, A.B., et al. J. Biol. Chem. 2011. July;286:23842-51.
4. Xu, X., et al. PLoS ONE. February 2011. 6:e17138.
| Artikelnummer | BPS27109 |
|---|---|
| Hersteller | BPS Bioscience |
| Hersteller Artikelnummer | 27109 |
| Green Labware | Nein |
| Verpackungseinheit | 5 mg |
| Mengeneinheit | STK |
| Produktinformation (PDF) |
|
| MSDS (PDF) |
|
Immer für Sie da
Gernot Ensinger, M.Sc.
Laurent Haze
